Skip to main content Accessibility help

Smokers who seek help in specialized cessation clinics: How special are they compared to smokers in general population?

  • Andriy V. Samokhvalov (a1) (a2) (a3), Peter Selby (a3) (a4) (a5), Susan J Bondy (a5) (a6), Michael Chaiton (a1) (a5) (a6), Anca Ialomiteanu (a1), Robert Mann (a1) (a5) and Jürgen Rehm (a1) (a3) (a5) (a7)...


Introduction: Patients of specialized nicotine dependence clinics are hypothesized to form a distinct subpopulation of smokers due to the features associated with treatment seeking. The aim of the study was to describe this subpopulation of smokers and compare it to smokers in general population.

Material and methods: A chart review of 796 outpatients attending a specialized nicotine dependence clinic, located in Toronto, Ontario, Canada was performed. Client smoking patterns and sociodemographic characteristics were compared to smokers in the general population using two Ontario surveys – the Ontario Tobacco Survey (n = 898) and the Centre for Addiction and Mental Health Monitor (n = 457).

Results: Smokers who seek treatment tend to smoke more and be more heavily addicted. They were older, had longer history of smoking and greater number of unsuccessful quit attempts, both assisted and unassisted. They reported lower education and income, had less social support and were likely to live with other smokers.

Conclusions: Smokers who seek treatment in specialized centers differ from the smokers in general population on several important characteristics. These same characteristics are associated with lower chances for successful smoking cessation and sustained abstinence and should be taken into consideration during clinical assessment and treatment planning.


Corresponding author

Corresponding author: Dr. Andriy V. Samokhvalov Centre for Addiction and Mental Health 33 Russell St, T519 M5V3R5, Toronto, OntarioCanada E-mail:


Hide All
Abrams, D. B., Orleans, C. T., Niaura, R., Goldstein, M. G., Prochaska, J. O., & Velicer, W. (1996). Integrating individual and public health perspectives for treatment of tobacco dependence under managed health care: a combined stepped-care and matching model. Annals of Behavioral Medicine, 18 (4), 290304.
Bertholet, N., Gaume, J., Faouzi, M., Gmel, G., & Daeppen, J. B. (2012). Predictive value of readiness, importance, and confidence in ability to change drinking and smoking. BMC Public Health, 12, 708. doi: doi: 10.1186/1471-2458-12-708
Bobak, M., Jha, P., Nguyen, S., & Jarvis, M. (2000). Poverty and smoking. Tobacco control in developing countries: Oxford Medical Publications.
Bulter-Jones, D. (2008). The Chief Public Health Officer's Report on The State of Public Health in Canada 2008. Ottawa: Public Health Agency of Canada.
Cahill, K., Stead, L. F., & Lancaster, T. (2012). Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews(4). doi:10.1002/14651858.CD006103.pub6
Coe, J. W., Rollema, H., & O'Neill, B. T. (2009). Case history: Chantix™/Champix™ (Varenicline Tartrate), a nicotinic acetylcholine receptor partial agonist as a smoking cessation aid. Annual Reports in Medicinal Chemistry, 44, 71101.
Cummins, S. E., Bailey, L., Campbell, S., Koon-Kirby, C., & Zhu, S. (2007). Tobacco cessation quitlines in North America: A descriptive study. Tobacco Control, 16(Suppl 1), i915.
Diemert, L., Victor, J. C., Chaiton, M., & Bondy, S. J. (2010). Ontario Tobacco Survey Technical Report 1:Baseline Data. Toronto, ON: Ontario Tobacco Research Unit.
Doran, C. M., Valenti, L., Robinson, M., Britt, H., & Mattick, R. P. (2006). Smoking status of Australian general practice patients and their attempts to quit. Addictive Behaviours, 31, 758766.
Fagerström, K., Russ, C., Yu, C. R., Yunis, C., & Foulds, J. (2012). The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: A pooled analysis of varenicline clinical trial data. Nicotine and Tobacco Research.
Hammond, D., McDonald, P. W., Fong, G. T., & Borland, R. (2004). Do smokers know how to quit? Knowledge and perceived effectiveness of cessation assistance as predictors of cessation behaviour. Addiction, 99 (8), 10421048.
Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerström, K. O. (1991). The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction, 86, 11191127.
Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., Rickert, W., & Robinson, J. (1989). Measuring the heaviness of smoking: Using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. British Journal of Addiction, 7, 791800.
Hughes, J. R., Stead, L. F., & Lancaster, T. (2007). Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews(1). doi: 10.1002/14651858.CD000031.pub3
Ialomiteanu, A., & Adlaf, E. A. (2012). CAMH Monitor 2011: Metadata User's eGuide. Toronto, Ontario: Centre for Addiction and Mental Health
Klingemann, H., Sobell, M. B., & Sobell, L. C. (2009). Continuities and changes in self-change research. Addiction. doi: Doi: 10.1111/j.1360-0443.2009.02770.x
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., . . . Aryee, M. (2013). A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet, 380 (9859), 22242260.
McCaul, K. D., Hockemeyer, J. R., Johnson, R. J., Zetocha, K., Quinlan, K., & Glasgow, R. E. (2006). Motivation to quit using cigarettes: A review. Addiictive Behaviour, 31, 4256.
Miller, W. R., & Rollnick, S. (2002). Motivational Interviewing.In Preparing People for Change. 2nd edition. New York, NY: The Guilford Press.
Niaura, R., & Abrams, D. B. (2002). Smoking cessation: progress, priorities and prospectus. Journal of Consulting and Clinical Psychology, 70 (3), 494509.
Okechukwu, C. A., Nguyen, K., & Hickman, N. J. (2010). Partner smoking characteristics: Associations with smoking and quitting among blue collar apprentices. American Journal of Industrial Medicine, 53 (11), 11021108.
Prochaska, J. O., & Goldstein, M. G. (1991). Process of smoking cessation. Implications for clinicians. Clinics In Chest Medicine, 12 (4), 727735.
Rehm, J., Gnam, W., Popova, S., Baliunas, D., Brochu, S., Fischer, B., . . . Taylor, B. (2007). The costs of alcohol, illegal drugs, and tobacco in Canada, 2002. Journal of Studies on Alcohol and Drugs, 68 (6), 886.
Reid, J., Hammond, D., Burkhalter, R., & Ahmed, R. (2012). Tobacco Use in Canada: Patterns and Trends, 2012 Edition. Waterloo, ON: Propel Centre for Population Health Impact. University of Waterloo.
Selby, P., Voci, S. C., Zawertailo, L. A., George, T. P., & Brands, B. (2010). Individualized smoking cessation treatment in an outpatient setting: Predictors of outcome in a sample with psychiatric and addictions co-morbidity. Addictive Behaviors, 811817. doi: 10.1016/j.addbeh.2010.03.020
Stead, L. F., & Lancaster, T. (2012). Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database of Systematic Reviews(10). doi: 10.1002/14651858.CD008286.pub2
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012). Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews(11). doi: 10.1002/14651858.CD000146.pub4
Williams, J. M., & Ziedonis, D. (2004). Addressing tobacco among individuals with a mental illness or an addiction. Addictive Behaviors, 29 (6), 10671083.
Woolacott, N., Jones, L., Forbes, C., Mather, L., Sowden, A., Song, F., . . . Barton, P. (2002). The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technology Assessment, 6 (16), 245pp.
Zhu, S., MelcerT., J., S T., J., S., Rosbrook, B., & Pierce, J. P. (2000). Smoking cessation with and without assistance: a population-based analysis. American Journal of Preventive Medicine, 18, 305311.


Smokers who seek help in specialized cessation clinics: How special are they compared to smokers in general population?

  • Andriy V. Samokhvalov (a1) (a2) (a3), Peter Selby (a3) (a4) (a5), Susan J Bondy (a5) (a6), Michael Chaiton (a1) (a5) (a6), Anca Ialomiteanu (a1), Robert Mann (a1) (a5) and Jürgen Rehm (a1) (a3) (a5) (a7)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed